NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction
Crossref DOI link: https://doi.org/10.1007/s12264-018-0321-8
Published Online: 2018-12-19
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Lin
Qiu, Xiaofei
Wang, Shuo
Wang, Qingshan
Zhao, Xiu-Lan
Text and Data Mining valid from 2018-12-19
Article History
Received: 24 April 2018
Accepted: 27 September 2018
First Online: 19 December 2018
Conflict of interest
: The authors declare that they have no conflict of interest.